Vanda Pharmaceuticals, Inc.
(NASDAQ : VNDA)

( )
VNDA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.00%204.730.0%$1981.02m
NVAXNovavax, Inc. 0.00%110.8278.2%$792.93m
BIIBBiogen, Inc. 0.00%239.301.8%$522.63m
AMGNAmgen, Inc. 0.00%235.361.4%$522.04m
BNTXBioNTech SE 0.00%196.000.0%$501.82m
GILDGilead Sciences, Inc. 0.00%71.771.0%$472.12m
ILMNIllumina, Inc. 0.00%405.143.3%$406.87m
REGNRegeneron Pharmaceuticals, Inc. 0.00%615.242.7%$388.21m
VRTXVertex Pharmaceuticals, Inc. 0.00%234.061.9%$331.63m
SNSSSunesis Pharmaceuticals, Inc. 0.00%3.170.7%$221.59m
EXASEXACT Sciences Corp. 0.00%78.4317.9%$151.61m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%148.508.2%$151.18m
ARNAArena Pharmaceuticals, Inc. 0.00%92.6513.7%$144.29m
INCYIncyte Corp. 0.00%74.882.4%$128.10m
BBIOBridgeBio Pharma, Inc. 0.00%12.750.0%$115.66m

Company Profile

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.